Merck KGaA (1MRK) AI Stock Analysis

2 Followers

Merck KGaA

(Milan:1MRK)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Manageable leverageManageable leverage and a larger equity base provide financial resilience across Merck KGaA’s three sectors. This supports continued investment in medicines, research tools and electronic materials while reducing the balance-sheet strain that can restrict strategic flexibility.

Negative Factors

Uneven revenue growthRevenue stagnation across 2023–2025 shows that the company’s diversified businesses have not delivered consistently expanding demand. A single TTM rebound is encouraging, but uneven growth can make operating leverage, planning and sustained earnings expansion less dependable.

Merck KGaA (1MRK) vs. iShares MSCI Italy ETF (EWI)

Market Cap: EUR 65.22B
Dividend Yield: 1.48%
Average Volume (3M): 114
Price to Earnings (P/E): 27.4
Beta (1Y): 0.65
Revenue Growth: -0.40%
EPS Growth: -17.22%
Country: Italy
Employees: 62,136
Sector: General
Sector Strength: 55
Industry: Drug Manufacturers - Specialty & Generic

Merck KGaA Business Overview & Revenue Model

Company Description

Merck KGaA is a German science and technology company with operations divided into three core segments: Life Science, Healthcare, and Electronics. The Life Science division supplies essential tools, chemicals, and equipment to academic research insti...

Merck KGaA Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

IT:1MRK against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
DE:FRE	73Outperform	EUR 27.09B	17.75	7.89%	2.15%	5.30%	35.29%
DE:SHL	70Outperform	EUR 48.43B	21.89	12.00%	2.31%	-0.92%	2.06%
DE:DMP	65Neutral	EUR 1.94B	13.88	22.38%	2.29%	0.39%	38.58%
DE:SRT	62Neutral	EUR 18.31B	72.47	7.81%	0.32%	4.19%	63.32%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
DE:EVT	41Neutral	EUR 498.87M	-2.58	-26.46%	―	-7.72%	-26.61%

* General Sector Average

Performance Comparison

IT:1MRK and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
IT:1MRK	Merck KGaA	150.10	42.31	39.26%
DE:EVT	Evotec AG (UK)	2.89	-2.93	-50.40%
DE:FRE	Fresenius SE & Co. KGaA	51.38	4.44	9.45%
DE:SRT	Sartorius (0NIQ)	227.50	52.26	29.82%
DE:DMP	Dermapharm Holding	38.90	6.27	19.20%
DE:SHL	Siemens Healthineers	44.85	1.60	3.70%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Merck KGaA AI Stock Analysis